Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 May 10;S1201-9712(20)30333-7.
doi: 10.1016/j.ijid.2020.05.026. Online ahead of print.

Use of Anakinra in Severe COVID-19: A Case Report

Affiliations
Free PMC article
Case Reports

Use of Anakinra in Severe COVID-19: A Case Report

Giovanni Filocamo et al. Int J Infect Dis. .
Free PMC article

Abstract

Coronavirus Disease 19 is a global healthcare emergency with high lethality rate. Relevant inflammatory cytokine storm is associated with severity of disease and IL1 inhibition is a cornerstone treatment for hyperinflammatory diseases. We present here the case of a patient with critical COVID-19 successfully treated with IL-1 receptor antagonist (anakinra).

Keywords: Anakinra; Biologic; COVID-19; IL-1; Treatment.

Similar articles

See all similar articles

Publication types

Feedback